Persistent transforming growth factor-beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence

American Journal of Nephrology

Volumn 18, Issue 6, 1998, Pages 513-519

  Lin, Ching Yuang ^a   Chen, Wei Perng ^a   Yang, Ling Yoeu ^a   Chen, Ann ^b   Huang, Tung Po ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Continuous ambulatory peritoneal dialysis; Peritoneal equilibration test; Peritonitis; Transforming growth factor beta 1

Indexed keywords

MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ADULT; ARTICLE; BIOPSY; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIALYSATE; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; HYBRIDIZATION; MONONUCLEAR CELL; PERITONEUM; PERITONITIS; PERMEABILITY; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROPERITONEAL FIBROSIS; SCHOOL CHILD;

EID: 0031743408     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000013397     Document Type: Article

References (22)

1. Popovich RP, Moncrief JW, Decherd JB: The definition of a novel portable/wearable equilibrium peritoneal dialysis technique (abstract). Trans Am Soc Artif Intern Organs 1976;22:64.
2. Slingeneyer A, Canaud B, Mion C: Permanent loss of ultrafiltration capacity of the peritoneum in long-term peritoneal dialysis: An epidemiological study. Nephron 1983;33:133-138.
3. Dobbie JW: Pathogenesis of peritoneal fibrosis syndromes (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int 1992;12:14-27.
4. Kovacs EJ: Fibrogenic cytokines: The role of immune mediators in the development of scar tissue. Immunol Today 1991;12:17-23.
5. Chaimovitz C: Peritoneal dialysis. Kidney Int 1994;45:1226-1240.
6. Ota K, Mesika M, Watanabe N: Functional deterioration of the peritoneum, docs it occur in the absence of peritonitis? Nephron Dial Transplant 1987;2:30-33.
7. Twardowski ZJ, Nolph KD, Khama R, Pro-want BF. Ryan LP, Moore HL, Nielsen MP: Peritoneal equilibration test. Pent Dial Bull 1987;7:138-147.
8. Chiou YY, Chen WP, Yang LY, Lin CY: Peritonitis in children being treated with continuous ambulatory peritoneal dialysis. Acta Paediatr Sin 1995;36:176-183.
9. Roberts AB, McCune BK, Sporn MB: TGF-β1: Regulation of extracellular matrix. Kidney Int 1992;41:557-559.
10. Border WA, Ruoslahti E: Transforming growth factor in disease: The dark side of tissue repair. J Clin Invest 1992;90:1-7.
11. Williams RS, Rossi AM. Chegini N. et al: Effect of transforming growth factor on postoperative adhesion formation and intact peritoneum. J Surg Res 1992;52:65-70.
12. Kagami S, Border WA, Ruoslahti E, et al: Coordinated expression of β1 integrins and transforming growth factor-β-induced matrix proteins in glomerulonephritis. Lab Invest 1993; 69:68-76.
13. Huang TP, Lin CY: Intraperitoneal recombinant human erythropoietin therapy: Influence of the duration of continuous ambulatory peritoneal dialysis treatment and peritonitis. Am J Nephrol 1995;15:312-317.
14. Lin CY, Huang TP: Gene expression and release of interleukin-8 by peritoneal macrophages and polymorphonuclear leukocytes during peritonitis in uremic patients on continuous peritoneal dialysis. Nephron 1994;68: 437-441.
15. Huang JL, Lin CY: A hereditary C3 deficiency due to aberrant splicing of exon 10. Clin Immunol Immunopathol 1994;73:267-273.
16. Glisin V, Crkvenjakov R, Byus C: Ribonucleic acid isolated by cesium chloride centrifugation. Biochemistry 1974;13:2633-2637.
17. Chen WP, Lin CY: Augmented expression of interleukin-6 and interleukin- I gene in the mesangium of IgM mesangial nephropathy. Nephron 1994;68:10-19.
18. Siegel S: Nonparametric Statistics for Behavioral Sciences. New York, McGraw-Hill, 1956.
19. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y. Pierschbacher MD, Ruoslahti E: Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease, nature 1992;360: 361-364.
20. Assolian RK, Fleurdelys BE, Stevenson HC, et al: Expression and secretion of type beta transforming growth factor by activated human macrophages. Proc Natl Acad Sci USA 1987; 84:6020-6024.
21. Kehrl JH, Wakefield LM, Robert AB, et al: Production of transforming growth factor beta human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 1986;163:1037-1050.
22. Wahl SM, Hunt DA. Wakefield LM, et al: Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci USA 1987;84: 5788-5790.